Chemotherapeutic agents and the skin: an update
N Heidary, H Naik, S Burgin - Journal of the American Academy of …, 2008 - Elsevier
Chemotherapeutic agents give rise to numerous well described adverse effects that may
affect the skin, hair, mucous membranes, or nails. The mucocutaneous effects of …
affect the skin, hair, mucous membranes, or nails. The mucocutaneous effects of …
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis syndrome in patients undergoing radiation therapy: a literature review
TZ Vern-Gross, A Kowal-Vern - American journal of clinical …, 2014 - journals.lww.com
Objective: Erythema multiforme (EM), Stevens Johnson syndrome (SJS), and toxic
epidermal necrolysis syndrome (TENS) are exfoliative disorders that may present as …
epidermal necrolysis syndrome (TENS) are exfoliative disorders that may present as …
Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines
SS Han, M Lee, GH Park, SH Bang… - British Journal of …, 2010 - academic.oup.com
Background Epidermal growth factor receptor (EGFR) critically regulates tumour cell
division, survival and metastasis. Agents that inhibit EGFR have been used in the treatment …
division, survival and metastasis. Agents that inhibit EGFR have been used in the treatment …
Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin
J Acharya, C Lyon, DM Bottomley - Journal of the American Academy of …, 2009 - Elsevier
Erlotinib, a specific epidermal growth factor receptor tyrosine kinase inhibitor, is used in
various metastatic cancers. It is known to cause acneiform rash. Herein, we report a case …
various metastatic cancers. It is known to cause acneiform rash. Herein, we report a case …
EMPACT syndrome: limited evidence despite a high-risk cohort
AJ Bishop, M Chang, ME Lacouture… - Journal of neuro-oncology, 2014 - Springer
Serious dermatologic adverse events such as erythema multiforme (EM) and Stevens-
Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have been reported in patients …
Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have been reported in patients …
Irradiated fields spared Stevens-Johnson syndrome in a patient undergoing radiotherapy for bone metastases
D Musio, E Parisi, F Dionisi, G Parisi, R Caiazzo… - Japanese journal of …, 2009 - Springer
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are two of the most
severe, rare, and life-threatening adverse reactions to medications. Their incidence is …
severe, rare, and life-threatening adverse reactions to medications. Their incidence is …
Endothelial growth factor receptor inhibition after radiotherapy
M Giovannini, V Gregorc, MG Viganò, A Spreafico… - Journal of Thoracic …, 2007 - jto.org
In 2005, a 62-year-old man was diagnosed with stage IIIB non-small cell lung cancer and
treated with sequential chemoradiotherapy. Approximately 2 years later, he was treated with …
treated with sequential chemoradiotherapy. Approximately 2 years later, he was treated with …
Cetuximab-induced acneiform eruption sparing a previously irradiated skin area
N Ormaechea-Pérez, A López-Pestaña… - … Cutánea Ibero-Latino …, 2014 - medigraphic.com
The acneiform eruption is the most frecuent cutaneous adverse effect of cetuximab. We
present a patient who developed an acneiform rash secundary to this drug that spared the …
present a patient who developed an acneiform rash secundary to this drug that spared the …
[PDF][PDF] Erlotinib-induced Acneiform Rash Not Affecting Previously Irradiated Skin
EAO por Erlotinib - infection, 2009 - Citeseer
Erlotinib is a tyrosine kinase inhibitor that acts by blocking the activity of the epidermal
growth factor receptor (EGFR). This receptor is frequently overexpressed and mutated in …
growth factor receptor (EGFR). This receptor is frequently overexpressed and mutated in …
Erupción acneiforme por cetuximab respetando la piel previamente irradiada
N Ormaechea-Pérez, A López-Pestaña… - … Cutánea Ibero-Latino …, 2014 - medigraphic.com
La erupción acneiforme es el efecto secundario cutáneo más frecuente de cetuximab.
Presentamos un paciente que desarrolló una erupción acneiforme secundaria a dicho …
Presentamos un paciente que desarrolló una erupción acneiforme secundaria a dicho …